Over 46k sought financial aid for cancer treatment

Chandigarh: While cancer continues to take a social and financial toll on the state, the Punjab government does not have the exact number of cancer patients in the state. It has, however, confirmed that more than 46,000 cancer patients applied for financial assistance during the last eight years. Bathinda and Mansa, meanwhile, have the highest incidence of cervical cancer.

For cashless treatment of cancer patients, financial assistance of up to Rs 1.50 lakh is given to government and empaneled hospitals. In 2017, Amritsar topped the list with 847 cancer patients applying for treatment, followed by 842 in Ludhiana, and 724 in Patiala.

“For prevention of cervical cancer, HPV vaccine has been introduced in the state. In the first phase, it has been administered to class VI girls in government schools of district Bathinda and Mansa, which have highest prevalence of cervical cancer in the state. The vaccine is being introduced in the rest of the state in a phased manner,” said health minister Brahm Mohindra in his reply to a question by MLA Davinder Singh Ghubaya.

Besides, the Centre has approved two 50-bedded tertiary cancer care centres in district Hoshiarpur and Fazilka at a cost of Rs 45 crore. A state cancer institute is being set up at government medical college in Amritsar, in collaboration with the union government. Tate Memorial Cancer Research Centre, Mumbai, is also setting up a 300-bedded Homi Bhabha Cancer Hospital and Research Centre in New Chandigarh.

  • Related Posts

    Piramal, Ajinomoto team on ADC development and manufacturing

    Piramal Pharma Solutions, a global contract development and manufacturing organization, and Ajinomoto Bio-Pharma Services announced a strategic collaboration to support development and manufacturing of antibody-drug conjugates (ADCs) using AJICAP technology…

    Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

    New Delhi: Aurobindo Pharma Ltd on Friday said it has received final approval from the US health regulator to manufacture and market its generic version of glycerol phenylbutyrate oral liquid…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Piramal, Ajinomoto team on ADC development and manufacturing

    Piramal, Ajinomoto team on ADC development and manufacturing

    Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

    Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

    Cancer cure must not be hostage to Big Pharma

    Cancer cure must not be hostage to Big Pharma

    GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

    GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

    Aurobindo Pharma gains after receving USFDA nod for Glycerol Phenylbutyrate Oral Liquid

    Aurobindo Pharma gains after receving USFDA nod for Glycerol Phenylbutyrate Oral Liquid

    Legal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In India

    Legal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In India